Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes

Completed · Phase 4 · Has a placebo group

Conditions studied: Atrial Fibrillation

In brief

The primary purpose of this study is to assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation.

Key facts

Study ID

NCT01206452

Run by

Dhanunjaya Lakkireddy, MD, FACC

People needed

60

Starts

2010-09-01

Expected to finish

2013-12-01

Last updated by the study team

2017-05-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Able to provide written informed consent;
• Scheduled for radiofrequency ablation procedure for treatment of atrial fibrillation

You may not qualify if…

• History of heart failure (right or left or biventricular) or cardiomyopathy.
• Immunosuppressive disorders and systemic fungal infection
• Concurrent use of corticosteroids in one week prior recruitment.
• Allergy or prednisone or its components.
• Other medical conditions were use of corticosteroids is not recommended or contraindicated.
• Patients with chronic and permanent atrial fibrillation.
• Patients with established diagnosis of rheumatological and immunological disorders.

Where it is running

• University Of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.